We are live on ! Find out more
USNA icon

Usana Health Sciences

165 hedge funds and large institutions have $307M invested in Usana Health Sciences in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 64 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

13% more capital inflows, than outflows

Capital inflows: $31.6M | Capital outflows: $27.8M

1.79% more ownership

Funds ownership: 59.13% → 60.92% (+1.8%)

7% more call options, than puts

Call options by funds: $531K | Put options by funds: $498K

1% more funds holding

Funds holding: 164 → 165 (+1)

20% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 64

Holders
165
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
51
Reduced
64
Closed
21
Calls
$531​K
Puts
$498​K
Net Calls
+$33​K
Net Calls Change
-⁠$214​K

USNA Hedge Fund Activity: Q3 2025 in Review

165 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2025, worth a combined $307M — down 8.8% from $336M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 21 closed out — a net gain of 3 holders — while 51 added to existing stakes and 64 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $3.85M. The largest seller was Citadel Advisors, cutting an estimated $3.52M.

  • 165 institutional investors held Usana Health Sciences (USNA) as of Q3 2025, up from 164 in Q2 2025.
  • Funds reported $307M of Usana Health Sciences stock for Q3 2025, down 8.8% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q3 2025 and 21 closed out, a net change of +3 holders.
  • The largest Usana Health Sciences buyer in Q3 2025 was Two Sigma Investments, an estimated $3.85M added.
  • The largest Usana Health Sciences seller in Q3 2025 was Citadel Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q3 2025.